Quantification of Blood Caffeine Levels in Patients With Parkinson's Disease and Multiple System Atrophy by Caffeine ELISA

Caffeine is considered to be a neuroprotective agent against Parkinson's disease (PD) and is expected to offer a blood-based biomarker for the disease. We herein investigated the ability of this biomarker to discriminate between PD and neurodegenerative diseases. To quantify caffeine concentrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohmichi, Takuma, Kasai, Takashi, Shinomoto, Makiko, Matsuura, Jun, Koizumi, Takashi, Kitani-Morii, Fukiko, Tatebe, Harutsugu, Sasaki, Hidenao, Mizuno, Toshiki, Tokuda, Takahiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783046/
https://www.ncbi.nlm.nih.gov/pubmed/33414755
http://dx.doi.org/10.3389/fneur.2020.580127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783046/
https://www.ncbi.nlm.nih.gov/pubmed/33414755
http://dx.doi.org/10.3389/fneur.2020.580127

Ejemplares similares